PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34073405-0	2021	Evaluation of Substituted N-Phenylpiperazine Analogs as D3 vs. D2 Dopamine Receptor Subtype Selective Ligands.	phenylpiperazine	26-44	dopamine receptor D2	Homo sapiens	63-83	
34073405-1	2021	N-phenylpiperazine analogs can bind selectively to the D3 versus the D2 dopamine receptor subtype despite the fact that these two D2-like dopamine receptor subtypes exhibit substantial amino acid sequence homology.	phenylpiperazine	0-18	dopamine receptor D2	Homo sapiens	69-89	
33988991-3	2021	Here, we examine the molecular basis for the high affinity D3R binding and D3R vs D2R binding selectivity of substituted phenylpiperazine thiopheneamides.	phenylpiperazine	121-137	dopamine receptor D2	Homo sapiens	82-85	
31214037-1	2019	LASSBio-579, an N-phenylpiperazine antipsychotic lead compound, has been previously reported as a D2 receptor (D2R) ligand with antipsychotic-like activities in rodent models of schizophrenia.	phenylpiperazine	16-34	dopamine receptor D2	Homo sapiens	98-109	
31214037-1	2019	LASSBio-579, an N-phenylpiperazine antipsychotic lead compound, has been previously reported as a D2 receptor (D2R) ligand with antipsychotic-like activities in rodent models of schizophrenia.	phenylpiperazine	16-34	dopamine receptor D2	Homo sapiens	111-114	
30010318-3	2018	Our goal was to investigate how the composition and size of the nonaromatic ring structure at the piperazine position of substituted phenylpiperazine analogues might influence binding affinity at the human D2 and D3 dopamine receptors.	phenylpiperazine	133-149	dopamine receptor D2	Homo sapiens	206-234